1. Home
  2. GRRR vs RGNX Comparison

GRRR vs RGNX Comparison

Compare GRRR & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gorilla Technology Group Inc.

GRRR

Gorilla Technology Group Inc.

HOLD

Current Price

$13.43

Market Cap

419.5M

Sector

Technology

ML Signal

HOLD

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$10.06

Market Cap

418.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRRR
RGNX
Founded
2001
2008
Country
United Kingdom
United States
Employees
200
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
419.5M
418.1M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
GRRR
RGNX
Price
$13.43
$10.06
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$28.75
AVG Volume (30 Days)
780.3K
671.4K
Earning Date
06-17-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.08
EPS
N/A
N/A
Revenue
N/A
$10,393,000.00
Revenue This Year
$69.35
$51.21
Revenue Next Year
$85.38
$19.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
126.48
52 Week Low
$9.04
$7.35
52 Week High
$27.90
$16.19

Technical Indicators

Market Signals
Indicator
GRRR
RGNX
Relative Strength Index (RSI) 50.13 56.32
Support Level $12.13 $7.76
Resistance Level $15.83 $10.65
Average True Range (ATR) 0.86 0.62
MACD -0.14 0.10
Stochastic Oscillator 33.39 53.89

Price Performance

Historical Comparison
GRRR
RGNX

About GRRR Gorilla Technology Group Inc.

Gorilla Technology Group Inc is engaged in providing information, software, and data processing services. It is a provider of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology (OT) security solutions and services. Its reportable segments are video IoT and security convergence and Other segments. Its expertise lies in revolutionizing urban operations, enhancing security, and optimizing digital transformation. It delivers pioneering products that integrate AI, deep learning, and edge computing to advance intelligent video surveillance, facial recognition, license plate recognition, post-event analytics, cybersecurity, and network intelligence.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

Share on Social Networks: